GSK pushes more data for shingles vaccine, but no filing yet
GlaxoSmithKline's shingles vaccine continues to demonstrate strong efficacy in all ages in Phase III trials but the company doesn't plan to file the product just yet.
GlaxoSmithKline's shingles vaccine continues to demonstrate strong efficacy in all ages in Phase III trials but the company doesn't plan to file the product just yet.